Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets.
|
31491891 |
2019 |
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets.
|
31491891 |
2019 |
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets.
|
31491891 |
2019 |
Impaired cognition
|
0.010 |
Biomarker
|
disease |
BEFREE |
Mutations in the TUBB5 are mainly responsible for microcephaly but the clinical spectrum is wide, from patients with severe developmental delay, and the presence of different brain malformations, to patients with only slightly cognitive impairment and normal motor development.
|
30738969 |
2019 |
Glioblastoma Multiforme
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, we elucidate GLUT1 (Glucose transporter 1) and one of its associated binding partners, TUBB4 (Tubulin 4), as potentially druggable targets in GBM.
|
31491891 |
2019 |
DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL
|
0.010 |
Biomarker
|
disease |
BEFREE |
Moreover, oligodendrocyte-specific proteins such as MAG and TUBB4 were decreased in the neuropils in both gray matter and white matter in CTE, which correlated with the degree of axonal injury and degeneration.
|
31308796 |
2019 |
Neuroblastoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To elucidate the pathogenic mechanisms conferred by TUBB4A mutations leading to the different phenotypes, we functionally characterized three pathogenic TUBB4A variants (c.4C>G,p.R2G; c.745G>A,p.D249N; c.811G>A, p.A271T) as representatives of the mutational and disease spectrum) in human neuroblastoma cells and human induced pluripotent stem cell (iPSC)-derived neurons.
|
30079973 |
2018 |
Henoch-Schoenlein Purpura
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in TUBB4A have been identified to cause a wide phenotypic spectrum of diseases ranging from hereditary generalized dystonia with whispering dysphonia (DYT-TUBB4A) and hereditary spastic paraplegia (HSP) to leukodystrophy hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
|
30079973 |
2018 |
Spastic Paraplegia, Hereditary
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in TUBB4A have been identified to cause a wide phenotypic spectrum of diseases ranging from hereditary generalized dystonia with whispering dysphonia (DYT-TUBB4A) and hereditary spastic paraplegia (HSP) to leukodystrophy hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).
|
30079973 |
2018 |
Central neuroblastoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To elucidate the pathogenic mechanisms conferred by TUBB4A mutations leading to the different phenotypes, we functionally characterized three pathogenic TUBB4A variants (c.4C>G,p.R2G; c.745G>A,p.D249N; c.811G>A, p.A271T) as representatives of the mutational and disease spectrum) in human neuroblastoma cells and human induced pluripotent stem cell (iPSC)-derived neurons.
|
30079973 |
2018 |
Childhood Neuroblastoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To elucidate the pathogenic mechanisms conferred by TUBB4A mutations leading to the different phenotypes, we functionally characterized three pathogenic TUBB4A variants (c.4C>G,p.R2G; c.745G>A,p.D249N; c.811G>A, p.A271T) as representatives of the mutational and disease spectrum) in human neuroblastoma cells and human induced pluripotent stem cell (iPSC)-derived neurons.
|
30079973 |
2018 |
Encephalopathies
|
0.010 |
GeneticVariation
|
group |
BEFREE |
We present a study of the cellular effects of TUBB4A mutations responsible for H-ABC (p.Asp249Asn), DYT4 (p.Arg2Gly), a severe combined phenotype with hypomyelination and encephalopathy (p.Asn414Lys), as well as milder phenotypes causing isolated hypomyelination (p.Val255Ile and p.Arg282Pro).
|
28973395 |
2017 |
Isovaleryl-CoA dehydrogenase deficiency
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in TUBB4A, encoding the tubulin isoform tubulin beta class IVA (Tubb4a), result in the symptom complex of hypomyelination with atrophy of basal ganglia and cerebellum (H-ABC).
|
28973395 |
2017 |
Spastic Quadriplegia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Additionally, TUBB4A mutations are known to result in a broad phenotypic spectrum, ranging from primary dystonia (DYT4), isolated hypomyelination with spastic quadriplegia, and an infantile onset encephalopathy, suggesting multiple cell types may be involved.
|
28973395 |
2017 |
Mental impairment
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We have previously reported that mutations in TUBB5 cause microcephaly that is accompanied by severe intellectual impairment and motor delay.
|
28130172 |
2017 |
Cervical Dystonia
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
A potentially pathogenic rare 3bp-in-frame deletion was found in a patient with cervical dystonia but no copy number variations were detected in this study, suggesting that TUBB4A mutations exceedingly rarely contribute to the etiology of isolated dystonia.
|
28655586 |
2017 |
nervous system disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
Our study adds complicated hereditary spastic paraplegia to the clinical spectrum of TUBB4A-associated neurological disorders.
|
25772097 |
2015 |
Pelizaeus-Merzbacher Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A de novo TUBB4A mutation in a patient with hypomyelination mimicking Pelizaeus-Merzbacher disease.
|
24974158 |
2015 |
Complicated hereditary spastic paraplegia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our study adds complicated hereditary spastic paraplegia to the clinical spectrum of TUBB4A-associated neurological disorders.
|
25772097 |
2015 |
Congenital Abnormality
|
0.010 |
GeneticVariation
|
group |
BEFREE |
By contrast, TUBB3 and TUBB5 mutations cause milder malformations with focal or multifocal polymicrogyria-like cortical dysplasia with abnormal and simplified gyral pattern.
|
24860126 |
2014 |
Mental disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
Moreover, given its allelic association with leukoencephalopathy hypomyelination with atrophy of basal ganglia and cerebellum and protean clinical manifestations (chorea, ataxia, dysarthria, intellectual disability, dysmorphic facial features, and psychiatric disorders), DYT4 should not be categorized as a primary dystonia.
|
24598712 |
2014 |
Abnormal behavior
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Moreover, given its allelic association with leukoencephalopathy hypomyelination with atrophy of basal ganglia and cerebellum and protean clinical manifestations (chorea, ataxia, dysarthria, intellectual disability, dysmorphic facial features, and psychiatric disorders), DYT4 should not be categorized as a primary dystonia.
|
24598712 |
2014 |
Polymicrogyria
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
By contrast, TUBB3 and TUBB5 mutations cause milder malformations with focal or multifocal polymicrogyria-like cortical dysplasia with abnormal and simplified gyral pattern.
|
24860126 |
2014 |
Cortical Dysplasia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
By contrast, TUBB3 and TUBB5 mutations cause milder malformations with focal or multifocal polymicrogyria-like cortical dysplasia with abnormal and simplified gyral pattern.
|
24860126 |
2014 |
Progressive Neoplastic Disease
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
The 25 patients with the common c.745G>A mutation generally had a less rapidly progressive disease course than the 17 cases with other TUBB4A mutations.
|
24785942 |
2014 |